USPTO trademark

TIMMARVA

Under examinationUSPTOWord markClass 5Class 42Class 44

"TIMMARVA" is a word mark owned by Hong Kong King-Friend, Industrial Company, Ltd., filed at the USPTO on September 17, 2026. It is under examination and covers classes 5, 42 and 44.

Get this data via the API
Official USPTO record
TIMMARVA trademark as filed
As filed with the USPTO
Status
Under examination
Since September 17, 2026
Filed
September 17, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50115076
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns TIMMARVA

The owner and representative on file with the office.

Owner

Hong Kong King-Friend, Industrial Company, Ltd.

Hong Kong, Hong Kong SAR China

Representative

Eric R. Moran

McDonnell Boehnen Hulbert & Berghoff LLP

Goods and services

What the mark covers

The products and services TIMMARVA is filed for, grouped by Nice class.

  • Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; biologics; biosimilars; pegfilgrastim biosimilars; pharmaceutical preparations for the treatment of neutropenia; pharmaceutical preparations for the treatment of low white blood cells; pharmaceutical preparations for use in stimulating white blood cell production; biosimilars for use in stimulating white blood cell production; pharmaceutical preparations, namely, recombinant-human granulocyte-CSF for use in stimulating white blood cell production; recombinant-human granulocyte-CSF biosimilars for use in stimulating white blood cell production; pharmaceutical preparations, namely, injectable pegfilgrastim biosimilars; pharmaceutical preparations, namely, injectable biosimilars for the treatment of neutropenia; pharmaceutical preparations, namely, injectable biosimilars for the treatment of low white blood cells; pharmaceutical preparations, namely, injectable biosimilars for use in stimulating white blood cell production; pharmaceutical preparations, namely, injectable recombinant-human granulocyte-CSF for use in stimulating white blood cell production; pharmaceutical preparations, namely, injectable recombinant-human granulocyte-CSF biosimilars for use in stimulating white blood cell production; injectors sold filled with pegfilgrastim biosimilars; injectors sold filled with pharmaceutical preparations for the treatment of neutropenia; injectors sold filled with pharmaceutical preparations for the treatment of low white blood cells; injectors sold filled with pharmaceutical preparations for use in stimulating white blood cell production; injectors sold filled with biosimilars for use in stimulating white blood cell production; injectors sold filled with recombinant-human granulocyte-CSF for use in stimulating white blood cell production; injectors sold filled with recombinant-human granulocyte-CSF biosimilars for use in stimulating white blood cell production

  • Providing information in the field of scientific and medical research related to pharmaceuticals; providing information in the field of scientific and medical research related to cancer and cancer treatments; research and development of pharmaceuticals; research and development of pharmaceuticals in the field of cancer and cancer treatments

  • Providing medical information; providing health information; providing medical information in the field of cancer and cancer treatments; providing health information in the field of cancer and cancer treatments; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About TIMMARVA

Who owns the trademark "TIMMARVA"?

The USPTO trademark "TIMMARVA" (application 50115076) is owned by Hong Kong King-Friend, Industrial Company, Ltd.

What is the status of "TIMMARVA"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull TIMMARVA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0b4a2-6a43-72f8-a4e9-d5c46822c1a9
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0b4a2-6a43-72f8-a4e9-d5c46822c1a9",
  "object": "trademark",
  "mark_text": "TIMMARVA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50115076",
  "filing_date": "2026-09-17",
  "nice_classes": [
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "Hong Kong King-Friend, Industrial Company, Ltd.",
      "entity_id": null
    }
  ]
}